*Treatment of disease-related splenomegaly or symptoms in patients with primary myelofibrosis, postpolycythaemia veramyelofibrosis, or post-essential thrombocythaemia myelofibrosis:* Adults: Platelets count 50000-100000/mm3: 5 mg twice daily; 100000-200000/mm3: 15 mg twice daily; >200000/ mm3: 20 m...
| Brand Name | Manufacturer / Company | Available Pack Sizes & Price | Action |
|---|---|---|---|
| JAKAVI | 🏢 NOVARTIS |
Tab 15 mg 60:
Rs.443125.88
Tab 15 mg 14:
Rs.547392.59
Tab 15 mg 56:
Rs.487438.47
|
View Details → |
Other generic formulations in the same therapeutic groups as RUXOLITINIB.